Vaccine. 2010 Jun 11;28(26):4249-59. Epub 2010 Apr 21.

Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development.

Source

Pfizer Inc., Paris, France.

Abstract

Streptococcus pneumoniae serotype 19A is associated with all forms of pneumococcal disease and was the first reported pneumococcal serotype with high-level penicillin and multidrug resistance. While the seven-valent pneumococcal conjugate vaccine (PCV7), which contains serotype 19F, has reduced rates of disease among children and adults, the incidence of disease due to nonvaccine and increasingly drug-resistant serotypes - predominantly serotype 19A - has increased. This review summarizes the published literature to analyze the factors contributing to the emergence of serotype 19A, the diseases associated with this serotype, and the importance of including this serotype in novel pneumococcal conjugate vaccines. A recently approved 13-valent vaccine includes this serotype, and is likely to significantly reduce the burden of disease due to serotype 19A.

PMID:: 20416266; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Pneumococcal Infections - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. [Pediatr Infect Dis J. 2010]
Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH Jr. Pediatr Infect Dis J. 2010 Apr; 29(4):294-300.
Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. [Pediatr Infect Dis J. 2007]
Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
Farrell DJ, Klugman KP, Pichichero M. Pediatr Infect Dis J. 2007 Feb; 26(2):123-8.
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. [J Infect Dis. 2005]
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B, Active Bacterial Core Surveillance Team. J Infect Dis. 2005 Dec 1; 192(11):1988-95. Epub 2005 Nov 1.
Review Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. [Clin Microbiol Infect. 2009]
Review Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
Dagan R. Clin Microbiol Infect. 2009 Apr; 15 Suppl 3:16-20.
Review Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. [Int J Infect Dis. 2010]
Review Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ, McIntosh ED, Reinert RR. Int J Infect Dis. 2010 Mar; 14(3):e197-209. Epub 2009 Aug 22.

See reviews... See all...

Cited by 4 PubMed Central articles

Immune response to 19A serotype after immunization of 19F containing pneumococcal conjugate vaccine in Korean children aged 12-23 months. [Korean J Pediatr. 2011]
Immune response to 19A serotype after immunization of 19F containing pneumococcal conjugate vaccine in Korean children aged 12-23 months.
Lee HJ, Park SE, Kim KH. Korean J Pediatr. 2011 Apr; 54(4):163-8. Epub 2011 Apr 30.
The changing epidemiology of Streptococcus pneumoniae serotype 19A clonal complexes. [J Infect Dis. 2011]
The changing epidemiology of Streptococcus pneumoniae serotype 19A clonal complexes.
Tyrrell GJ. J Infect Dis. 2011 May 15; 203(10):1345-7. Epub 2011 Mar 11.
Review A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children. [Curr Opin Pediatr. 2011]
Review A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children.
Grijalva CG, Pelton SI. Curr Opin Pediatr. 2011 Feb; 23(1):98-104.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Pneumococcal disease caused by serotype 19A: review of the literature and implic...
Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development.
Vaccine. 2010 Jun 11 ;28(26):4249-59. Epub 2010 Apr 21 .

PubMed
Identification of type 2 diabetes-associated combination of SNPs using support v...
Identification of type 2 diabetes-associated combination of SNPs using support vector machine.
BMC Genet. 2010 Apr 23 ;11:26.

PubMed
Preclinical detection in studies of the etiology, natural history, and treatment...
Preclinical detection in studies of the etiology, natural history, and treatment of Parkinson's disease.
Neurology. 1991 May ;41(5 Suppl 2):14-20.

PubMed
A phase III study of belatacept versus cyclosporine in kidney transplants from e...
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).
Am J Transplant. 2010 Mar ;10(3):547-57.

PubMed
The potential for airborne dispersal of Clostridium difficile from symptomatic p...
The potential for airborne dispersal of Clostridium difficile from symptomatic patients.
Clin Infect Dis. 2010 Jun 1 ;50(11):1450-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: